These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3541415

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
    Akhras F, Jackson G.
    Lancet; 1991 Oct 26; 338(8774):1036-9. PubMed ID: 1681355
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-ischemic effects of slow-release formulations of nifedipine, isosorbide-5-mononitrate and their combination in patients with coronary heart disease.
    Erlemeier HH, Kupper W, Hempel NB, Bleifeld W.
    Cardiology; 1988 Oct 26; 75(6):409-18. PubMed ID: 3228824
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R, Scrutinio D, Mangini SG, De Toma L, Accettura D, De Nicolò M, Saliani P, Preziusi N, Antuofermo F, Rizzon P.
    G Ital Cardiol; 1985 Mar 26; 15(3):299-306. PubMed ID: 4018470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris.
    Svendsen JH, Aldershvile J, Abildgaard U, Amtorp O.
    J Cardiovasc Pharmacol; 1989 Sep 26; 14(3):358-63. PubMed ID: 2476613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO.
    Can J Cardiol; 1991 Apr 26; 7(3):125-30. PubMed ID: 2044014
    [Abstract] [Full Text] [Related]

  • 17. Nifedipine and isosorbide dinitrate alone and in combination for patients with chronic stable angina: a double-blind crossover study.
    Vlay SC, Olson LC.
    Am Heart J; 1990 Aug 26; 120(2):303-7. PubMed ID: 2200253
    [Abstract] [Full Text] [Related]

  • 18. Influence of isosorbide 5-mononitrate 20 mg, sustained-release 50 mg and sustained-release nifedipine 20 mg on ischaemic ST-segment changes during Holter monitoring. A double-blind cross-over study in patients with spontaneous angina pectoris.
    von Arnim T.
    Cardiology; 1987 Aug 26; 74 Suppl 1():40-5. PubMed ID: 3300977
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
    Hennig L, Andresen D, Hennig A, Levenson B, Brüggemann T, Schröder R.
    J Clin Pharmacol; 1991 Jul 26; 31(7):636-40. PubMed ID: 1894759
    [Abstract] [Full Text] [Related]

  • 20. [Intraindividual dose-response relationship of sustained-release Elantan].
    Kenedi P.
    Z Kardiol; 1986 Jul 26; 75 Suppl 3():77-9. PubMed ID: 3541420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.